Deutsche Bank Aktiengesellschaft Trims Clorox (NYSE:CLX) Target Price to $151.00

Clorox (NYSE:CLX) had its target price cut by Deutsche Bank Aktiengesellschaft from $155.00 to $151.00 in a research report released on Wednesday, Benzinga reports. They currently have a hold rating on the stock.

CLX has been the topic of several other research reports. UBS Group boosted their price objective on Clorox from $145.00 to $170.00 and gave the company a neutral rating in a report on Friday, February 2nd. Jefferies Financial Group raised Clorox from an underperform rating to a hold rating and set a $145.00 target price for the company in a research report on Tuesday, March 26th. Citigroup reduced their price target on shares of Clorox from $165.00 to $155.00 and set a neutral rating on the stock in a research report on Tuesday. Barclays dropped their price objective on shares of Clorox from $148.00 to $136.00 and set an underweight rating for the company in a report on Wednesday, April 10th. Finally, The Goldman Sachs Group started coverage on shares of Clorox in a report on Friday, March 1st. They set a sell rating and a $140.00 target price on the stock. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to data from MarketBeat.com, Clorox has a consensus rating of Hold and an average price target of $148.63.

Clorox Trading Up 0.3 %

Shares of CLX stock opened at $143.58 on Wednesday. The company has a 50-day moving average of $149.99 and a two-hundred day moving average of $141.79. The firm has a market cap of $17.82 billion, a PE ratio of 227.90, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. Clorox has a 1-year low of $114.68 and a 1-year high of $178.21. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The firm’s quarterly revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the company posted $0.98 EPS. On average, analysts predict that Clorox will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a yield of 3.34%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 761.90%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Retirement Guys Formula LLC lifted its stake in Clorox by 15.3% during the first quarter. Retirement Guys Formula LLC now owns 4,061 shares of the company’s stock worth $622,000 after purchasing an additional 538 shares during the last quarter. KFG Wealth Management LLC lifted its position in shares of Clorox by 15.5% during the 1st quarter. KFG Wealth Management LLC now owns 4,677 shares of the company’s stock worth $716,000 after buying an additional 628 shares during the last quarter. Albion Financial Group UT lifted its position in shares of Clorox by 5.8% during the 1st quarter. Albion Financial Group UT now owns 31,246 shares of the company’s stock worth $4,784,000 after buying an additional 1,712 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of Clorox by 0.3% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 326,479 shares of the company’s stock valued at $49,987,000 after buying an additional 923 shares in the last quarter. Finally, Silverlake Wealth Management LLC purchased a new position in shares of Clorox in the 1st quarter valued at $352,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.